首页> 外国专利> A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.

A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.

机译:持续释放制剂的药物组合物本发明涉及持续释放制剂的药物组合物,其包含生理活性肽。

摘要

A sustained-release preparation which comprises a physiologically active peptide of general formula CHEM wherein X represents an acyl group; R1, R2 and R4 each represents an aromatic cyclic group; R3 represents a D-amino acid residue or a group of the formula CHEM wherein R3' is a heterocyclic group; R5 represents a group of the formula -(CH2)n-R5' wherein n is 2 or 3, and R5' is an amino group which may optionally be substituted, an aromatic cyclic group or an O-glycosyl group; R6 represents a group of the formula -(CH2)n-R6' wherein n is 2 or 3, and R6' is an amino group which may optionally be substituted; R7 represents a D-amino acid residue or an azaglycyl residue; and Q represents hydrogen or a lower alkyl group, or a salt thereof and a biodegradable polymer having a terminal carboxyl group. The sustained-release preparation shows a constant release of the peptide over a long time without an initial burst.
机译:一种缓释制剂,其包含通式的生理活性肽,其中X代表酰基; R 1,R 2和R 4分别表示芳族环状基团。 R3代表D-氨基酸残基或式的基团,其中R3'是杂环基; R5表示式-(CH2)n-R5'的基团,其中n为2或3,并且R5'为可任选被取代的氨基,芳族环状基团或O-糖基基团; R6代表式-(CH2)n-R6'的基团,其中n为2或3,R6'为可任选取代的氨基; R7代表D-氨基酸残基或氮杂糖基残基; Q表示氢或低级烷基或其盐和具有末端羧基的生物降解性聚合物。持续释放制剂显示肽在长时间内恒定释放而没有初始爆发。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号